Free Trial

Option Care Health Q2 2024 Earnings Report

Option Care Health logo
$22.92 +0.01 (+0.04%)
(As of 05:45 PM ET)

Option Care Health EPS Results

Actual EPS
$0.30
Consensus EPS
$0.27
Beat/Miss
Beat by +$0.03
One Year Ago EPS
$0.63

Option Care Health Revenue Results

Actual Revenue
$1.23 billion
Expected Revenue
$1.17 billion
Beat/Miss
Beat by +$60.42 million
YoY Revenue Growth
+14.80%

Option Care Health Announcement Details

Quarter
Q2 2024
Time
Before Market Opens

Conference Call Resources

Your chance to get on the next “60-Second Trade” (Ad)

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

Just head over here!

Option Care Health Earnings Headlines

UBS Initiates a Hold Rating on Option Care Health (OPCH)
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
Option Care Health (OPCH) Gets a Buy from Truist Financial
Jefferies Remains a Hold on Option Care Health (OPCH)
See More Option Care Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Option Care Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Option Care Health and other key companies, straight to your email.

About Option Care Health

Option Care Health (NASDAQ:OPCH) offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

View Option Care Health Profile

More Earnings Resources from MarketBeat

Upcoming Earnings